Moreover, the IL-15 immunotherapy may be a feasible strategy for COVID-19, as it induces innate immune responses via the induction of NK cells, CD8+ T cells, and T regulatory cells to neutralize Th2 cytokine storms, leading to decreased levels of IL-4, IL-5, and IL-13. The gene discussed is IL13; the disease is COVID-19.